AMRS
Amyris is a biotechnology company that uses microorganisms to convert abundant plant-derived sugars into high-performing molecules at scale. Its platform enables renewable biological chemistry, unlocking the production of sustainable products and new market opportunities across various industries. The company emphasizes precision fermentation, strain and process development, piloting, and manufacturing capabilities to scale solutions globally. Headquartered with a global footprint, Amyris focuses on delivering environmentally sustainable chemistry and resilient supply chains.
No recent deals for this company.